EA200602138A1 - 1-ГЕТЕРОЦИКЛИЛ-1,5-ДИГИДРОПИРИДО[3,2-b]ИНДОЛ-2-ОНЫ - Google Patents

1-ГЕТЕРОЦИКЛИЛ-1,5-ДИГИДРОПИРИДО[3,2-b]ИНДОЛ-2-ОНЫ

Info

Publication number
EA200602138A1
EA200602138A1 EA200602138A EA200602138A EA200602138A1 EA 200602138 A1 EA200602138 A1 EA 200602138A1 EA 200602138 A EA200602138 A EA 200602138A EA 200602138 A EA200602138 A EA 200602138A EA 200602138 A1 EA200602138 A1 EA 200602138A1
Authority
EA
Eurasian Patent Office
Prior art keywords
substituted
indol
hydrogen
methanimidamidyl
het
Prior art date
Application number
EA200602138A
Other languages
English (en)
Other versions
EA012330B1 (ru
Inventor
Барт Рудольф Романи Кестелейн
Пьер Жан-Мари Бернар Рабуассон
Доминик Луи Нестор Гилэйн Сюрлеро
Жервен Ивонн Поль Аше
Сандрин Мари Элен Вендевилль
Анник Анн Петерс
Пит Том Берт Поль Вигеринк
Original Assignee
Тиботек Фармасьютикалз Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Тиботек Фармасьютикалз Лтд. filed Critical Тиботек Фармасьютикалз Лтд.
Publication of EA200602138A1 publication Critical patent/EA200602138A1/ru
Publication of EA012330B1 publication Critical patent/EA012330B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Изобретение описывает 1-гетероциклил-1,5-дигидро-пиридо[3,2-b]индол-2-оны формулы (I): N-оксиды, соли, стереоизомерные формы, рацемические смеси, пролекарства, сложные эфиры и их метаболиты, в которой n представляет 1, 2 или 3; Rпредставляет водород, циано, галоид, замещенный карбонил, метанимидамидил, N-гидроксиметанимидамидил, моно- или ди(Cалкил)метанимидамидил, Hetили Het; X представляет NR, О, S, SO, SO; Rпредставляет водород, Cалкил, Салкенил, Сциклоалкил, которые являются необязательно замещенными; Rпредставляет арил, замещенный группой -COOR; или Rпредставляет: (b-1); (b-2); -CH-CH(OR)-CH-R(b-3); -СН-СН-(O-СН-СН)-OR(b-4 ); -CH-CH-(O-CH-CH)-NRR(b-5); -a=a-a=a- представляет -CH=CH-CH=CH-; -N=CH-CH=CH-; -CH=N-CH=CH-; -CH=CH-N=CH-; -CH=CH-CH=N-; где атомы водорода в (с-1)-(с-5) могут быть заменены определенными радикалами; Rпредставляет моноциклическую или бициклическую ароматическую гетероциклическую кольцевую систему, которая может быть замещенной.
EA200602138A 2004-05-17 2005-05-17 1-ГЕТЕРОЦИКЛИЛ-1,5-ДИГИДРОПИРИДО[3,2-b]ИНДОЛ-2-ОНЫ EA012330B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04102171 2004-05-17
PCT/EP2005/052264 WO2005111047A1 (en) 2004-05-17 2005-05-17 1-heterocyclyl-1,5-dihydro-pyrido[3,2-b]indol-2-ones

Publications (2)

Publication Number Publication Date
EA200602138A1 true EA200602138A1 (ru) 2007-04-27
EA012330B1 EA012330B1 (ru) 2009-08-28

Family

ID=34929106

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200602138A EA012330B1 (ru) 2004-05-17 2005-05-17 1-ГЕТЕРОЦИКЛИЛ-1,5-ДИГИДРОПИРИДО[3,2-b]ИНДОЛ-2-ОНЫ

Country Status (17)

Country Link
US (1) US7615639B2 (ru)
EP (1) EP1758911A1 (ru)
JP (1) JP4898668B2 (ru)
KR (1) KR20070015608A (ru)
CN (1) CN1953983B (ru)
AP (1) AP2006003791A0 (ru)
AR (1) AR049340A1 (ru)
AU (1) AU2005243439B2 (ru)
BR (1) BRPI0511175A (ru)
CA (1) CA2564027A1 (ru)
EA (1) EA012330B1 (ru)
IL (1) IL178555A0 (ru)
MX (1) MXPA06013314A (ru)
NO (1) NO20065898L (ru)
TW (1) TW200607503A (ru)
WO (1) WO2005111047A1 (ru)
ZA (1) ZA200610587B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1953978B (zh) * 2004-05-17 2010-09-29 泰博特克药品有限公司 作为抗病毒剂的5-取代的1-苯基-1,5-二氢-吡啶并[3,2-b]吲哚-2-酮及其类似物
US20070049603A1 (en) * 2005-09-01 2007-03-01 Greg Miknis Raf inhibitor compounds and methods of use thereof
EP2004647A1 (en) 2006-04-03 2008-12-24 Tibotec Pharmaceuticals Ltd. Hiv inhibiting 3,4-dihydro-imidazoý4,5-b¨pyridin-5-ones
WO2008037783A1 (en) * 2006-09-29 2008-04-03 Tibotec Pharmaceuticals Ltd. Process for preparing 2-oxo-2,5-dihydro-1h-pyrido[3,2-b]indole-3-carbonitriles
WO2010115264A1 (en) 2009-04-09 2010-10-14 Boehringer Ingelheim International Gmbh Inhibitors of hiv replication
AU2011252351A1 (en) * 2010-05-14 2012-10-11 Affectis Pharmaceuticals Ag Novel methods for the preparation of P2X7R antagonists
EP3241830A1 (de) 2016-05-04 2017-11-08 Bayer CropScience Aktiengesellschaft Kondensierte bicyclische heterocyclen-derivate als schädlingsbekämpfungsmittel
KR102435080B1 (ko) 2016-07-19 2022-08-22 바이엘 크롭사이언스 악티엔게젤샤프트 해충 방제제로서의 축합 바이시클릭 헤테로사이클 유도체

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
PH30929A (en) 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
RU2170082C2 (ru) 1993-10-01 2001-07-10 Астра Актиеболаг Способ обработки лекарственного средства, устройство для формирования лекарственного средства и лекарственное средство
US5612330A (en) * 1994-03-07 1997-03-18 Warner-Lambert Company Methods for inhibiting and controlling viral growth
CA2240161C (en) 1996-05-20 2005-05-24 Janssen Pharmaceutica N.V. Antifungal compositions with improved bioavailability
IL129575A (en) 1997-03-26 2004-06-20 Janssen Pharmaceutica Nv Pills with a core coated with a fungicide and polymer
US6596729B2 (en) * 2000-07-20 2003-07-22 Bristol-Myers Squibb Company Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors
WO2002059123A2 (en) * 2000-12-18 2002-08-01 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Benzoylalkylindolepyridinium compounds and pharmaceutical compositions comprising such compounds
US20020182151A1 (en) 2000-12-18 2002-12-05 The Government Of The U.S.A. As Represented By The Secretary Of The Dept. Of Health & Human Services Benzoylalkylindolepyridinium componds and pharmaceutical compositions comprising such compounds
US20030096833A1 (en) 2001-08-31 2003-05-22 Jagtap Prakash G. Substituted ideno[1,2-c]isoquinoline derivatives and methods of use thereof
BR0316209A (pt) 2002-11-15 2005-09-27 Tibotec Pharm Ltd Indolpiridìnio substituìdo como compostos antiinfecciosos

Also Published As

Publication number Publication date
US7615639B2 (en) 2009-11-10
CA2564027A1 (en) 2005-11-24
AU2005243439B2 (en) 2011-09-29
IL178555A0 (en) 2007-02-11
MXPA06013314A (es) 2007-02-02
AP2006003791A0 (en) 2006-10-31
NO20065898L (no) 2007-02-19
JP4898668B2 (ja) 2012-03-21
TW200607503A (en) 2006-03-01
CN1953983A (zh) 2007-04-25
EP1758911A1 (en) 2007-03-07
AR049340A1 (es) 2006-07-19
WO2005111047A1 (en) 2005-11-24
BRPI0511175A (pt) 2007-12-04
EA012330B1 (ru) 2009-08-28
US20070265295A1 (en) 2007-11-15
KR20070015608A (ko) 2007-02-05
AU2005243439A1 (en) 2005-11-24
CN1953983B (zh) 2010-05-26
JP2007538051A (ja) 2007-12-27
ZA200610587B (en) 2008-08-27

Similar Documents

Publication Publication Date Title
EA200602138A1 (ru) 1-ГЕТЕРОЦИКЛИЛ-1,5-ДИГИДРОПИРИДО[3,2-b]ИНДОЛ-2-ОНЫ
TW200613307A (en) 4-substituted-1,5-dihydro-pyrido[3,2-b]indol-2-ones
EA201100975A1 (ru) Производные 1,2,4-оксадиазола и их применение в терапии
PE20120172A1 (es) Compuestos heterociclicos fusionados que contiene nitrogeno como inhibidores de la produccion de beta-amiloide
UA100400C2 (ru) Производные спироциклических амидов
AR031556A1 (es) Derivados de 3-(diarilmetilen)-8-azabiciclo[3.2.1] octano y composiciones farmaceuticas que los comprenden
AR052458A1 (es) Amino-imidazolonas para la inhibicion de beta-secretasa
CO6620074A2 (es) Derivados de pirrolo [2, 3-b] piridinas para la inhibicion de quinasas raf
EP2308877A4 (en) Imidazopyridine-2-ON DERIVATIVE
EA201001188A1 (ru) Связанные мостиковой связью бициклические гетероциклические или спиробициклические гетероциклические производные пиразоло[1,5-a]пиримидинов, способы их получения и их применения
AR070274A1 (es) Derivados arilamida diazepinopirimidona sustituidos utiles en el tratamiento y/o prevencion de enfermedades neurodegenerativas y otras, provocadas por la actividad anormal de quinasas gsk3beta, medicamentos que los contienen y proceso de preparacion e intermediarios.
NO20076680L (no) Utvalgte CGRP-antagonister, metoder for fremstilling av disse og deres anvendelse som medikamenter
CO5690551A2 (es) Derivados de tetrazol y metodos para el tratamiento con los mismos de trastornos relacionados con el metabolismo
WO2010033643A3 (en) Small molecule compounds for stem cell differentiation
NZ594508A (en) [1, 2, 4] triazolo [1, 5 -a] pyridines as kinase inhibitors
CO6220973A2 (es) Nuevos compuestos triciclicos sustituidos que comprenden 3 a 5 atomos de nitrogeno, derivados de un sistema saturado de 1, 3-diazepina, su preparacion y su utilizacion como medicamentos antibacterianos
TW200607502A (en) 6, 7, 8, 9-substituted 1-phenyl-1, 5-dihydro-pyrido[3, 2-b]indol-2-ones
WO2008155670A3 (en) Arylamide pyrimidone compounds
EA200971062A1 (ru) Производные ариламидпиримидона
PE20160040A1 (es) Nuevos compuestos inhibidores de la fosfodiesterasa del tipo 10a
MXPA05013631A (es) Derivado heterociclico de metilsulfona.
PE20091167A1 (es) Derivados heterociclicos con actividad sobre los receptores de ampa
TW200510320A (en) Aminoquinoline derivatives and their use as adenosine A3 ligands
EA201691690A1 (ru) Производные этинила
AR066873A1 (es) Derivados de triazolo (1,5-a) quinolina, procesos de obtencion y composiciones farmaceuticas

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU